Patents by Inventor Steven Michael Foord

Steven Michael Foord has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer
    Patent number: 6861441
    Abstract: The present invention relates to the use of an EP4 receptor ligand in the manufacture of a medicament for use in the treatment of neuropathic pain, colon cancer, migraine, and for increasing the latency of HIV infection.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: March 1, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Nicholas Maughan Clayton, Susanne Denise Collins, Steven Michael Foord, Gerard Martin Paul Giblin, Richard John Coles, Mark Bamford, Jennifer M Doughty, Richard Green
  • Medicaments
    Publication number: 20040254224
    Abstract: A method of treating HM74A and/or HM74 mediated disease in an individual which comprises administering to the individual a therapeutic amount of a modulator of HM74A and/or HM74 activity.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 16, 2004
    Inventors: Steven Michael Foord, Nicholas Brian Pike, Alan Wise
  • Novel receptor
    Publication number: 20030082801
    Abstract: The present invention relates to the novel GABAB receptor subtypes GABAB-R1c and GABAB-R2 as well as to a novel, functional GABAB receptor which comprises a heterodimer of GABAB-R1 and GABAB-R2 receptor subunits. The present invention also relates to variants of the receptors, nucleotide sequences encoding the receptors and variants thereof and novel vectors, stable cell lines, antibodies, screening methods, methods of treatment and methods of receptor production.
    Type: Application
    Filed: November 20, 2002
    Publication date: May 1, 2003
    Inventors: Ashley Anthony Barnes, Alan Wise, Fiona Hamilton Marshall, Neil James Fraser, Julia Helen Margaret White, Steven Michael Foord
  • Receptor
    Patent number: 6518399
    Abstract: The present invention relates to the novel GABAB receptor subtypes GABAB-R1c and GABAB-R2 as well as to a novel, functional GABAB receptor which comprises a heterodimer of GABAB-R1 and GABAB-R2 receptor subunits. The present invention also relates to variants of the receptors, nucleotide sequences encoding the receptors and variants thereof and novel vectors, stable cell lines, antibodies, screening methods, methods of treatment and methods of receptor production.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: February 11, 2003
    Assignee: Smithkline Beecham Corporation
    Inventors: Ashley Antony Barnes, Alan Wise, Fiona Hamilton Marshall, Neil James Fraser, Julia Helen Margaret White, Steven Michael Foord
  • Novel protein
    Publication number: 20020115102
    Abstract: A purinergic like polypeptide comprises
    Type: Application
    Filed: January 24, 2001
    Publication date: August 22, 2002
    Inventors: Diane Joan Cousens, Steven Michael Foord, Diane Michele Ignar, Filippo Volpe
  • Assay
    Publication number: 20020052001
    Abstract: A method for identification of a compound that modulates GPR 17 activity comprises contacting a GPR 17 polypeptide with a test compound; and monitoring for cysteinyl leukotriene-receptor activity. The GPR 17 polypeptide has the amino acid sequence of SEQ ID NO: 2; or is a variant thereof which is capable binding a leukotriene such as LTD4, LTE4, LTC4 or LTF4. It can thereby be determined whether the test substance is a modulator of GPR 17 activity.
    Type: Application
    Filed: February 16, 2001
    Publication date: May 2, 2002
    Inventors: Diane Joan Cousens, Steven Michael Foord, Filippo Volpe